Earnings estimate | Current qtr. (Mar 2022) | Next qtr. (Jun 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 0 | 0 | 0 | 0 |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low estimate | 0 | 0 | 0 | 0 |
High estimate | 0 | 0 | 0 | 0 |
Year ago EPS | N/A | N/A | N/A | N/A |
Revenue estimate | Current qtr. (Mar 2022) | Next qtr. (Jun 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 199.89B | 179.84B | 10.09B | 11.43B |
Low estimate | 199.89B | 179.84B | 10.09B | 11.43B |
High estimate | 199.89B | 179.84B | 10.09B | 11.43B |
Year ago sales | N/A | N/A | 900.08B | 10.09B |
Sales growth (year/est) | N/A | N/A | -98.90% | 13.20% |
Earnings history | Invalid Date | Invalid Date | 30/09/2021 | 31/12/2021 |
---|---|---|---|---|
Est. EPS | N/A | N/A | 117.02 | 105.96 |
Actual EPS | N/A | N/A | 109.61 | 89.71 |
Difference | N/A | N/A | -7.41 | -16.25 |
Surprise % | N/A | N/A | -6.30% | -15.30% |
EPS trend | Current qtr. (Mar 2022) | Next qtr. (Jun 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Current estimate | 0 | 0 | 0 | 0 |
7 days ago | 64.96 | 61.84 | 3.07 | 3.14 |
30 days ago | 64.96 | 61.84 | 3.07 | 3.14 |
60 days ago | 64.96 | 61.84 | 3.07 | 3.14 |
90 days ago | 64.96 | 61.84 | 3.07 | 3.14 |
EPS revisions | Current qtr. (Mar 2022) | Next qtr. (Jun 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | CHMF.ME | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | N/A | N/A | N/A | N/A |
Next qtr. | N/A | N/A | N/A | N/A |
Current year | N/A | N/A | N/A | N/A |
Next year | N/A | N/A | N/A | N/A |
Next 5 years (per annum) | 71.70% | N/A | N/A | N/A |
Past 5 years (per annum) | 90.00% | N/A | N/A | N/A |